Search Results

Idelalisib reduces regulatory T cells and activates T helper 17 cell differentiation in relapsed refractory patients with chronic lymphocytic leukaemia.

• Authors : Gadi D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.

Subjects: Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/Leukemia, Lymphocytic, Chronic, B-Cell*/drug therapy ; T-Lymphocytes, Regulatory*; Cell Differentiation

• Source: British journal of haematology [Br J Haematol] 2022 Apr; Vol. 197 (2), pp. 207-211. Date of Electronic Publication: 2022 Feb 15.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

The predictive value of regulatory T cells on glucocorticoid sensitivity in patients with immune thrombocytopenia: a multicentre, prospective clinical study.

• Authors : Li L; Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.; Zhao Y

Subjects: CD8-Positive T-Lymphocytes/CD8-Positive T-Lymphocytes/CD8-Positive T-Lymphocytes/*metabolism ; Glucocorticoids/Glucocorticoids/Glucocorticoids/*administration & dosage ; Purpura, Thrombocytopenic, Idiopathic/Purpura, Thrombocytopenic, Idiopathic/Purpura, Thrombocytopenic, Idiopathic/*blood

• Source: British journal of haematology [Br J Haematol] 2021 May; Vol. 193 (3), pp. 619-627. Date of Electronic Publication: 2021 Mar 10.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Therapeutic use of regulatory T cells for graft-versus-host disease.

• Authors : Elias S; Howard Hughes Medical Institute and Immunology Program and Ludwig Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Rudensky AY

Subjects: Graft vs Host Disease/Graft vs Host Disease/Graft vs Host Disease/*therapy ; Lymphocyte Transfusion/Lymphocyte Transfusion/Lymphocyte Transfusion/*methods ; T-Lymphocytes, Regulatory/T-Lymphocytes, Regulatory/T-Lymphocytes, Regulatory/*transplantation

• Source: British journal of haematology [Br J Haematol] 2019 Oct; Vol. 187 (1), pp. 25-38. Date of Electronic Publication: 2019 Aug 16.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Reduced regulatory T cells (Treg) in bone marrow preferentially associate with the expansion of cytotoxic T lymphocytes in low risk MDS patients.

• Authors : Giovazzino A; Dipartimento di Scienze Mediche Traslazionali, Università di Napoli 'Federico II', Napoli, Italy.; Leone S

Subjects: Bone Marrow Cells/Bone Marrow Cells/Bone Marrow Cells/*immunology ; Myelodysplastic Syndromes/Myelodysplastic Syndromes/Myelodysplastic Syndromes/*immunology ; T-Lymphocytes, Cytotoxic/T-Lymphocytes, Cytotoxic/T-Lymphocytes, Cytotoxic/*pathology

• Source: British journal of haematology [Br J Haematol] 2019 Apr; Vol. 185 (2), pp. 357-360. Date of Electronic Publication: 2018 Jul 16.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Charcot–Leyden crystals in acute myeloid leukaemia associated with basophilia.

• Authors : Chiriac, Radu¹ (AUTHOR); Humbert, Carole¹ (AUTHOR); Mejri, Amira² (AUTHOR)

Subjects: *ACUTE myeloid leukemia; *REGULATORY T cells; *CRYSTALS

• Source: British Journal of Haematology. Dec2023, Vol. 203 Issue 5, p699-700. 2p.

Record details

Beneficial role of increased FOXP3 + regulatory T-cells in acute myeloid leukaemia therapy response.

• Authors : Menter T; Institute of Pathology and Genetics, University Hospital Basel, Basel, Switzerland.; Kuzmanic B

Subjects: Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/immunology ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/mortality ; Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/Leukemia, Myeloid, Acute*/pathology

• Source: British journal of haematology [Br J Haematol] 2018 Aug; Vol. 182 (4), pp. 581-583. Date of Electronic Publication: 2017 Jun 27.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Regulatory T cells are replenished in the splenic microenvironment of patients with immune thrombocytopenia by treatment with thrombopoietin receptor agonists.

Subjects: *THROMBOPOIETIN receptor agonists; *REGULATORY T cells; *IDIOPATHIC thrombocytopenic purpura

• Source: British Journal of Haematology. Sep2022, Vol. 198 Issue 5, p803-804. 2p.

Record details

Serological response to SARS‐CoV‐2 mRNA‐containing lipid nanoparticle vaccine in patients with multiple myeloma: A negative impact of CD38+ regulatory T cells?

• Authors : Baron, Frédéric¹ (AUTHOR) ; Caers, Jo¹ (AUTHOR); Humblet‐Baron, Stéphanie² (AUTHOR)

Subjects: *REGULATORY T cells; *MULTIPLE myeloma; *T cell receptors

• Source: British Journal of Haematology. May2022, Vol. 197 Issue 4, p391-393. 3p.

Record details

Indirect induction of regulatory T cells accompanies immune responses during peptide vaccination of chronic lymphocytic leukaemia patients.

• Authors : Skorka K; Department of Experimental Haematooncology, Medical University of Lublin, Lublin, Poland.; Zaleska J

Subjects: Immunity, Cellular*; Leukemia, Lymphocytic, Chronic, B-Cell/Leukemia, Lymphocytic, Chronic, B-Cell/Leukemia, Lymphocytic, Chronic, B-Cell/*immunology ; T-Lymphocytes, Regulatory/T-Lymphocytes, Regulatory/T-Lymphocytes, Regulatory/*immunology

• Source: British journal of haematology [Br J Haematol] 2016 Jul; Vol. 174 (1), pp. 155-7. Date of Electronic Publication: 2015 Aug 25.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

In vitro TNF blockade enhances ex vivo expansion of regulatory T cells in patients with immune thrombocytopenia.

• Authors : Zhong H; Laboratory of Complement Biology, New York Blood Center, New York, NY, USA.; Bussel J

Subjects: Antibodies/Antibodies/Antibodies/*immunology ; Purpura, Thrombocytopenic, Idiopathic/Purpura, Thrombocytopenic, Idiopathic/Purpura, Thrombocytopenic, Idiopathic/*immunology ; Purpura, Thrombocytopenic, Idiopathic/Purpura, Thrombocytopenic, Idiopathic/Purpura, Thrombocytopenic, Idiopathic/*therapy

• Source: British journal of haematology [Br J Haematol] 2015 Jan; Vol. 168 (2), pp. 274-83. Date of Electronic Publication: 2014 Sep 24.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details